0001562180-21-007617.txt : 20211209 0001562180-21-007617.hdr.sgml : 20211209 20211209184222 ACCESSION NUMBER: 0001562180-21-007617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211207 FILED AS OF DATE: 20211209 DATE AS OF CHANGE: 20211209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horstmeier Paul CENTRAL INDEX KEY: 0001780978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 211483179 MAIL ADDRESS: STREET 1: C/O HEALTH CATALYST, INC. STREET 2: 3165 E. MILLROCK DRIVE #400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-12-07 false 0001636422 Health Catalyst, Inc. HCAT 0001780978 Horstmeier Paul C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false Chief Operating Officer Common Stock 2021-12-07 4 S false 2082.00 39.9688 D 91035.00 D Common Stock 2021-12-07 4 S false 400.00 40.61 D 90635.00 D The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $39.46 to $40.42 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $40.58 to $40.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). /s/ Daniel Orenstein, as Attorney-in-Fact 2021-12-09